Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease

Patients with acute venous thromboembolism (VTE) require anticoagulant therapy to prevent recurrent VTE and death, which exposes them to an inherent increased risk of bleeding. Identification of patients at high risk of bleeding, and mitigating this risk, is an essential component of the immediate a...

Descripción completa

Detalles Bibliográficos
Autores principales: den Exter, Paul L., Woller, Scott C., Robert‐Ebadi, Helia, Masias, Camila, Morange, Pierre‐Emmanuel, Castelli, David, Hansen, John‐Bjarne, Geersing, Geert‐Jan, Siegal, Deborah M., de Wit, Kerstin, Klok, Frederikus A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Isth Ssc Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545751/
https://www.ncbi.nlm.nih.gov/pubmed/35735219
http://dx.doi.org/10.1111/jth.15776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545751/
https://www.ncbi.nlm.nih.gov/pubmed/35735219
http://dx.doi.org/10.1111/jth.15776

Ejemplares similares